Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vericel (VCEL) Inventory: 2014-2025

Historic Inventory for Vericel (VCEL) over the last 12 years, with Sep 2025 value amounting to $18.2 million.

  • Vericel's Inventory rose 15.23% to $18.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.2 million, marking a year-over-year increase of 15.23%. This contributed to the annual value of $17.4 million for FY2024, which is 32.75% up from last year.
  • Vericel's Inventory amounted to $18.2 million in Q3 2025, which was up 7.87% from $16.8 million recorded in Q2 2025.
  • In the past 5 years, Vericel's Inventory ranged from a high of $18.2 million in Q3 2025 and a low of $10.3 million during Q1 2021.
  • Over the past 3 years, Vericel's median Inventory value was $15.4 million (recorded in 2023), while the average stood at $15.3 million.
  • Its Inventory has fluctuated over the past 5 years, first skyrocketed by 53.96% in 2021, then decreased by 24.56% in 2023.
  • Over the past 5 years, Vericel's Inventory (Quarterly) stood at $13.4 million in 2021, then grew by 19.47% to $16.0 million in 2022, then declined by 18.13% to $13.1 million in 2023, then soared by 32.75% to $17.4 million in 2024, then grew by 15.23% to $18.2 million in 2025.
  • Its Inventory stands at $18.2 million for Q3 2025, versus $16.8 million for Q2 2025 and $17.1 million for Q1 2025.